pifithrin has been researched along with Akinetic-Rigid Variant of Huntington Disease in 1 studies
pifithrin: a tetrahydrobenzothiazol; inhibitor of P53 that protects mice from the side effects of cancer therapy; structure in first source
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ehrnhoefer, DE | 1 |
| Skotte, NH | 1 |
| Ladha, S | 1 |
| Nguyen, YT | 1 |
| Qiu, X | 1 |
| Deng, Y | 1 |
| Huynh, KT | 1 |
| Engemann, S | 1 |
| Nielsen, SM | 1 |
| Becanovic, K | 1 |
| Leavitt, BR | 1 |
| Hasholt, L | 1 |
| Hayden, MR | 1 |
1 other study available for pifithrin and Akinetic-Rigid Variant of Huntington Disease
| Article | Year |
|---|---|
p53 increases caspase-6 expression and activation in muscle tissue expressing mutant huntingtin.
Topics: Animals; Benzothiazoles; Caspase 6; Cells, Cultured; Disease Models, Animal; Female; Fibroblasts; Hu | 2014 |